ASTHMA SLIDE RULE
1. Questions for prescriber to ask themselves and a person with asthma
Using this slide rule, how much short-acting beta2 agonist (SABA) also known as reliever/rescue/ salbutamol/’blue’ inhaler would you think was acceptable for a person with asthma to take in a year, week or day before you thought a review was necessary? What made you choose that?
Number of SABA inhalers Rx per year
2
Puffs of SABA used per year*
400
Puffs of SABA used per week
8
Puffs of SABA used per day
1
Increasing SABA use
Symptoms
*Some devices do not contain 200 puffs. Check the number in the devices you prescribe/dispense or use, and modify these messages accordingly
Suggestion:
Try asking a person with asthma the following question before asking question 1:'In the past 4 weeks, how often have you used your reliever/blue inhaler each day?'
Asthma Slide Rule
2. Questions for prescriber to ask themselves and a person with asthma
Reflecting on your answer to Question 1, and using the number scale 0–10 below, select the number that reflects:
  • How important is it that you organise a review? What made you select [number]? What would have made it a higher number [eg 8]
  • How confident do you feel to have a conversation about their poor control of asthma? What made you select [number]? What would have made it a higher number [eg 8]?

Note: BTS/SIGN 2016 advises that "Anyone prescribed more than one short-acting bronchodilator inhaler device a month should be identified and have their asthma assessed urgently; ICS should be considered for anyone using a SABA 3 times a week or more. “NICE 2017 advise that 3 or more days a week with required use of a SABA for symptomatic relief” constitutes a pragmatic threshold for uncontrolled asthma

Created and designed by IPCRG www.theipcrg.org. The Asthma Right Care initiative is a global movement led by the International Primary Care Respiratory Group (IPCRG) funded by AstraZeneca globally. The adaptation for the UK, production and distribution of this slide rule in the UK has been supported by AstraZeneca UK Limited. To find out more about the Asthma Right Care Initiative, visit www.pcrs-uk.org/asthmarightcare. The Primary Care Respiratory Society, is a registered charity; (Charity No: 1098117) and a company limited by guarantee registered in England (Company No: 4298947). VAT Registration Number: 866 1543 09. Registered offices: PCRS-UK, Miria House, 1683B High Street, Knowle, Solihull B93 0LL. Telephone: +44 (0)1675 477600. Email:info@pcrs-uk.org Website: http://www.pcrs-uk.org

GB-16041 - Date of preparation: March 2019
Asthma Right Care Guidance Notes available at www.pcrs-uk.org/asthmarightcare